Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(13%)
Results Posted
50%(3 trials)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_4
2
25%
Ph phase_2
3
38%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
3(37.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (37.5%)
Phase 42 (25.0%)
N/A3 (37.5%)

Trials by Status

enrolling_by_invitation113%
recruiting113%
completed675%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_4

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

NCT06246396
enrolling_by_invitationphase_2

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

NCT05826912
completedphase_2

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

NCT02203552
completedphase_2

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

NCT02297412
completedphase_4

Locally Delivered Minocycline in Advanced Periodontitis

NCT04076098
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06246396Phase 4

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

Recruiting
NCT05826912Phase 2

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

Enrolling By Invitation
NCT02203552Phase 2

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Completed
NCT02297412Phase 2

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Completed
NCT04076098Phase 4

Locally Delivered Minocycline in Advanced Periodontitis

Completed
NCT01053156Not Applicable

Trial of Minocycline to Treat Children With Fragile X Syndrome

Completed
NCT02312297Not Applicable

Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fasting Conditions

Completed
NCT02312609Not Applicable

Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8